Unigestion Holding Sa Eli Lilly & CO Transaction History

Unigestion Holding Sa

$1.68 Billion
Q1 2025

A detailed history of Unigestion Holding Sa transactions in Eli Lilly & CO stock. As of the latest transaction made, Unigestion Holding Sa holds 4,012 shares of LLY stock, worth $3.46 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

4,012

Previous 1,553 158.34%

Holding current value

$3.46 Million

Previous $1.2 Million 176.54%

% of portfolio

0.2%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 10, 2025	BUY	$725.72 - $929.72 $1.78 Million - $2.29 Million	2,459 Added 158.34%	4,012 $3.31 Million
Q4 2024 Feb 13, 2025	SELL	$727.2 - $932.06 $154,166 - $197,596	-212 Reduced 12.01%	1,553 $1.2 Million
Q3 2024 Nov 19, 2024	SELL	$772.14 - $960.02 $347,463 - $432,009	-450 Reduced 20.32%	1,765 $1.56 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $419,699 - $526,334	579 Added 35.39%	2,215 $2.01 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $342,883 - $458,730	-579 Reduced 26.14%	1,636 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $433,281 - $510,782	-825 Reduced 27.14%	2,215 $1.29 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $361,670 - $498,617	-832 Reduced 21.49%	3,040 $1.63 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $320,225 - $428,178	-913 Reduced 19.08%	3,872 $1.82 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $371,824 - $436,689	-1,197 Reduced 20.01%	4,785 $1.64 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $270,102 - $314,722	840 Added 16.34%	5,982 $2.19 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $64,336 - $73,317	217 Added 4.41%	5,142 $1.7 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $84,733 - $99,490	-304 Reduced 5.81%	4,925 $1.6 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $556,449 - $691,525	-2,371 Reduced 31.2%	5,229 $1.5 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $84,093 - $104,360	374 Added 5.18%	7,600 $2.1 Million
Q3 2021 Oct 14, 2021	BUY	$221.6 - $272.71 $1.34 Million - $1.65 Million	6,035 Added 506.72%	7,226 $1.67 Million
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $646,549 - $836,306	-3,581 Reduced 75.04%	1,191 $273,000
Q1 2021 May 05, 2021	SELL	$164.32 - $212.72 $2.01 Million - $2.61 Million	-12,261 Reduced 71.98%	4,772 $892,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $1.45 Million - $1.92 Million	-11,151 Reduced 39.57%	17,033 $2.87 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $25 Million - $29 Million	-171,255 Reduced 85.87%	28,184 $4.16 Million
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $2.67 Million - $3.21 Million	19,547 Added 10.87%	199,439 $32.7 Million
Q1 2020 Apr 30, 2020	SELL	$119.05 - $147.35 $15.7 Million - $19.4 Million	-131,755 Reduced 42.28%	179,892 $24.9 Million
Q3 2019 Nov 04, 2019	BUY	$106.79 - $116.16 $24,988 - $27,181	234 Added 0.08%	311,647 $34.9 Million
Q2 2019 Jul 15, 2019	SELL	$110.79 - $129.32 $19.5 Million - $22.8 Million	-176,336 Reduced 36.15%	311,413 $34.5 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $10.3 Million - $12.1 Million	-92,516 Reduced 15.94%	487,749 $63.3 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $9.35 Million - $10.5 Million	-88,288 Reduced 13.21%	580,265 $67.1 Million
Q3 2018 Nov 05, 2018	SELL	$85.86 - $107.31 $7.28 Million - $9.09 Million	-84,739 Reduced 11.25%	668,553 $71.7 Million
Q2 2018 Jul 24, 2018	BUY	$75.7 - $86.88 $57 Million - $65.4 Million	753,292 New	753,292 $64.3 Million

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

779M

Call Options Held

16.9M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $820B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Unigestion Holding Sa with notifications on news.

Account

Unigestion Holding Sa Eli Lilly & CO Transaction History